Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Cash from Investing Activities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Cash from Investing Activities for 2 consecutive years, with -$7.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 67.87% to -$7.4 million in Q4 2025 year-over-year; TTM through Oct 2025 was -$27.5 million, a N/A change, with the full-year FY2025 number at -$23.3 million, down 90.6% from a year prior.
  • Cash from Investing Activities was -$7.4 million for Q4 2025 at Kestra Medical Technologies, up from -$8.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$4.1 million in Q1 2025 to a low of -$8.2 million in Q3 2025.